MicroTech Medical (Hangzhou) Co., Ltd. Stock

Equities

2235

CNE100004QN6

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. 10:06:06 2024-05-05 pm EDT 5-day change 1st Jan Change
4.16 HKD +1.46% Intraday chart for MicroTech Medical (Hangzhou) Co., Ltd. +2.72% -35.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2023 253M 35.12M 274M Sales 2024 * 366M 50.74M 397M Capitalization 1.6B 222M 1.73B
Net income 2023 -125M -17.34M -135M Net income 2024 * -83M -11.51M -89.95M EV / Sales 2023 2.26 x
Net cash position 2023 1.89B 262M 2.04B Net cash position 2024 * 1.68B 233M 1.82B EV / Sales 2024 * -0.22 x
P/E ratio 2023
-20.1 x
P/E ratio 2024 *
-19 x
Employees 760
Yield 2023 *
-
Yield 2024 *
-
Free-Float 26.61%
More Fundamentals * Assessed data
Dynamic Chart
MicroTech Medical Co., Ltd. Appoints Shi Yonghui as Joint Company Secretary CI
MicroTech Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Microtech Medical Co., Ltd Announces Resignation of Duo Bo as Joint Company Secretary CI
Microtech Medical Co., Ltd. Announces Committee Changes CI
MicroTech Medical Co., Ltd. commences an Equity Buyback Plan for 17,384,044 shares, representing 4.08% of its issued share capital, under the authorization approved on May 18, 2023. CI
MicroTech Medical Co., Ltd. Announces Change of Joint Company Secretary CI
MicroTech Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
MicroTech Medical Completes Conversion to H Shares MT
MicroTech Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
MicroTech Medical Gets Regulatory Nod to Convert 3.5 Million Domestic Shares into Hong Kong Shares MT
Microtech Medical Co., Ltd. Announces Executive Changes CI
Microtech Medical Co., Ltd. Announces Executive Changes CI
Certain H Shares of MicroTech Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-OCT-2022. CI
MicroTech Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Certain H Shares of MicroTech Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-APR-2022. CI
More news
1 day+1.46%
1 week+2.72%
Current month+2.21%
1 month+1.71%
3 months-2.12%
6 months-0.95%
Current year-35.00%
More quotes
1 week
4.00
Extreme 4
4.16
1 month
3.88
Extreme 3.88
4.55
Current year
3.76
Extreme 3.76
6.28
1 year
3.40
Extreme 3.4
6.88
3 years
3.40
Extreme 3.4
31.70
5 years
3.40
Extreme 3.4
31.70
10 years
3.40
Extreme 3.4
31.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 10-12-31
Chief Tech/Sci/R&D Officer 54 11-02-28
Chief Administrative Officer 41 13-11-30
Members of the board TitleAgeSince
Chief Executive Officer 54 10-12-31
Director/Board Member 43 16-06-30
Director/Board Member 45 20-07-31
More insiders
Date Price Change Volume
24-05-05 4.16 +1.46% 20 700
24-05-03 4.1 +0.49% 73,100
24-05-02 4.08 +0.25% 152,900
24-04-30 4.07 +0.49% 12,500
24-04-29 4.05 0.00% 78,500

Delayed Quote Hong Kong S.E., May 05, 2024 at 10:06 pm EDT

More quotes
MicroTech Medical Hangzhou Co Ltd is a China-based company that mainly engaged in research, production and commercialization of diabetes treatment and diabetes monitoring. The Company's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The Company's products, such as artificial pancreas, are in the process of research and development. The Company's products are sold to overseas markets such as the United States and the European Union.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
3.798 CNY
Average target price
5.266 CNY
Spread / Average Target
+38.64%
Consensus